![]() |
T5 JobMesse für Pharmaberater/Klinikreferenten/Medizinprodukteberater
21.03.2012: Stuttgart – Haus der Wirtschaft - Willi-Bleicher-Str. 19, 70174 Stuttgart
> Anmeldung
13.06.2012: Berlin – Kongresszentrum Adlershof – Rudower Chaussee 17, 12489 Berlin
> Anmeldung
Projekt-Team GmbH – Personalberatung
Aktuelle Außendienstpositionen: Pharma, Klinik, MPB
www.projekt-team.de
|
|||||||
![]() |
|
|
LinkBack | Themen-Optionen | Ansicht |
|
|||
|
KAG Krankenanstaltengesetz (Österreich)
KAG Konzertierte Aktion im Gesundheitswesen KBS Konformitätsbewertungsstellen KBV Kassenärztliche Bundesvereinigung (s. KV) KHG Krankenhausfinanzierungsgesetz KRG Krebsregistergesetz KV Kassenärztliche Vereinigung auf Landesebene s. KBV
__________________
Wer versucht, mich zu ändern, ....muß mit Nebenwirkungen rechnen! |
|
|||
|
LAN Local Area Network
LASV Landesamt für Soziales und Versorgung LIF Swedish Pharmaceutical Industry Association LKP Leiter der Klinischen Prüfung nach AMG LLT Lowest Level Term (siehe MedDRA) LME Landesamt für Meß- und Eichwesen LMHV Lebensmittelhygiene-Verordnung LOA Letter of Agreement LOC Letter of Clarification LOCF Last-observation-carried-forward LOI Letter of Indemnification LOI Letter of Intend LPCA Last Evaluation, Predefined Change – Abnormal LPI Last Patient In LPO Last Patient Out LREC Local Research Ethics Committee LRS Laser Recording Systems
__________________
Wer versucht, mich zu ändern, ....muß mit Nebenwirkungen rechnen! |
|
|||
|
MA Marketing Application
MA Medicines Agency MAA Marketing Authorization Application MAA Marketing Authorization Approval MAGOYSZ Hungarian Pharmaceutical Manufacturers Association MAH Marketing Authorization Holder MANSEV Market Authorisation by Network Submission and Evaluation MANSEV Market Authorisation by Network Submission and Evaluation MAPP Manual of Practice Procedures MBO Muster-Berufsordnung für Ärztinnen/Ärzte in der BRD MC Managed Care MCA Medicines Control Agency (UK) MCA Multiple Classification Analysis MCA Medicines Control Agency, UK MCB Manufacturer’s Cell Bank MCO Managed Care Organization Mcomp Managed Competition MCT Multicentre Clinical Trial MDA Medical Devices Agency (UK) MDC Medical Documentation Center MDD Medical Device Directives (EU) MDK Medizinische Dienste der Krankenkassen MDR Medical Device Reporting (USA) MDS Medizinische Dienste der Spitzenverbände der GKV MDV Medical Device Vigilance MED Minimal Effective Dose MED- LARS Medical Literature Analysis and Retrieval System MEDDEV MEDical DEVice MedDRA Medical Dictionary for Drug Regulatory Activities MEDDRA Medical Dictionary for Drug Regulatory Affairs MedR Medizinrecht MEFA Danish Domestic Pharmaceutical Industry Association MEMO Medicines Evaluation and Monitoring Organisation MERS Multiagency Electronic Regulatory Submission MERS Multi-agency Electronic Regulatory Submission MESH Medical Subjects Headings MFPM Member of the Faculty of Pharmaceutical Medicine MFRG Mutual Recognition Facilitation MHS Message Handling Services (Austausch von Dokumenten) MHW Ministry of Health and Welfare (Koseisho – Japan) MINE Medical Information Network for Europe (EMEA) MIS Management Information System MNC Multinational Company MoH Ministry of Health MOU Memorandum of Understanding MP-BetreibV Medizinprodukte-Betreiberverordnung MPD Medical Product Directive MPG Gesetz über Medizinprodukte “Medizinproduktegesetz” MPI Manufacturing Process Information MPL Manufacturing, Packaging and Labelling (Protocol) MPV Verordnung über Medizinprodukte (Medizinprodukte-Verordnung) MPVerschrV Verordnung über die Verschreibungspflicht von Medizinprodukten MPVertV Verordnung über Vertriebswege für Medizinprodukte MR Mutual Recognition MRA Medical Research Associate MRA Mutual Recognition Agreement MRC Medical Research Council MRD Maximum Repeatable Dose MREC Multicentre Research Ethics Committee (UK) MRER Medical Research Event Report MRFG Mutual Recognition Facilitation Group (Gruppe von Behördenvertreter der CPMP — Medicines Control Agency, um unterschiedliche Beurteilungen im gegenseitigen EUAnerkennungsverfahren auszugleichen und zentrale Zulassungsverfahren zu erleichtern) MRL Maximum Residue Limit MRP Materials Requirement Planning MRP Mutual Recognition Procedure MS EC Member State bei gemeinsamen Zulassungen siehe auch CMS MSSO Maintenance and Support Services Organisation MTA Medical Technology Assessment MTD Maximum Tolerated Dose MVP Master Validation Plan MW Ministerium für Wirtschaft, Mittelstand und Technologie MWCB Manufacturer’s Working Cell Bank
__________________
Wer versucht, mich zu ändern, ....muß mit Nebenwirkungen rechnen! |
|
|||
|
NADA New Animal Drug Application (animal drugs)
NAF Notice of Adverse Findings (FDA post-audit letter) NAI No Action Indicated (FDA post-audit letter) NAPM National Association of Pharmaceutical Manufacturers (USA) NAS New Active Substance (UK) NAS-NRC National Academy of Sciences-National Research Council NATRIC National Reporting and Investigation Centre (UK) NB Notified Bodies NC New Combination NCE New Chemical Entity NCHS National Center for Health Statistics NCI National Cancer Institute (USA) NCL National Consumers League (USA) NCP Normal Clinical Practice NCPIE National Council on Patient Information and Education NCR paper No Carbon Required Paper NDA New Drug Application (FDA – human drugs) NDAB National Drugs Advisory Board (Ireland) NDAS New Drug Application Summary NDF New Dosage Form NDMA Non-prescription Drug Manufacturers Association NDS New Drug Study NE-FARMA The Dutch Association of the Innovative Pharmaceutical Industry NEL No Effect Level NfG Note for Guidance NGO Non-government Organisation NH&MRC National Health and Medical Research Council (Australien) NHI National Health Institute NHLBI National Heart, Lung and Blood Institute NHS National Health Service (UK) NHW National Health and Welfare Department (Canada) NIAID National Institute of Allergies and Infectious Diseases (USA) NICE National Institute for Clinical Excellence (Effectiveness) (UK) NIDA National Institute on Drug Abuse NIEHS National Institute of Environmental Health Science (USA) NIH National Institute of Health (USA) NINDS National Institute of Neurological Disorder and Stroke NIOSH National Institute for Occupational Safety and Health NLM National Library of Medicine NLN Nordic Council of Medicines NME New Molecular Entity (incl. Biologics and Biotech) NNT Number Needed/Necessary to Treat NOAEL No Observed Adverse Effect Level NOEC No Observed Effect Concentration NOG Gesetz zur Neuordnung von Selbstverwaltung und Eigenverantwortung in der gesetzlichen Krankenversicherung NOPR Notice of Public Release NOS Not Otherwise Specified NRB Noninstitutional Review Board (independent review board) NRZ Nationale Referenzzentren NtA (NTA) Notice to Applicants der EU - CPMP-Zulassungshinweise für den Anmelder NTI Narrow Therapeutic Index NTIS National Technical Information Service NTP National Toxicology Program NUB Neue Untersuchungs- und Behandlungsmethoden - Richtlinien des Bundesausschusses der Spitzenverbände der Ärzte und Krankenkassen NUB-Ausschuß Unterausschuß für neue Untersuchungs- und Behandlungsmethoden des Bundesausschusses der Spitzenverbände der Ärzte und Krankenkassen NUIS Non-Urgent Information System (EMEA) NVA National Vaccine Authority (USA) NVAC National Vaccine Advisory Committee NW Nebenwirkung siehe UAW
__________________
Wer versucht, mich zu ändern, ....muß mit Nebenwirkungen rechnen! |
|
|||
|
OAI Official Action Indicated (letter)
OC Office of Compliance (FDA) OCPB Office of Clinical Pharmacology and Biopharmaceuticals OCR Optical Character Recognition ODE Office of Device Evaluation (FDA) ODE Orphan Drug Exclusivity OECD Organisation for Economic Cooperation and Development ÖES Ökonomische Evaluations-Studien OGD Office of Generic Drugs (FDA) OGD Office of Govemment Drugs OGE Office of Government Ethics OID Optimal Immunomodulatory Dose OJC Official Journal of the European Communities OJL Official Joumal of the EU – L Series (Legislation) OMD Orphan Medical Drugs siehe OMP OMB Office of Management and Budget (USA) OMCL Official Medicines Control Laboratories OMP Orphan Medicinal Product OMR Outcome Monitoring Review ONDC Office of New Drug Chemistry (USA) OPCS Office of Population, Censuses and Surveys (UK) OPD Office of Orphan Products Development (FDA) OPDRA Office of Post-Marketing Drug Risk Assessment (FDA) OPPI Organisation of Pharmaceutical Producers of India OPRR Office of Protection from Research Risks OPS Office of Pharmaceutical Science (FDA) ORI (Division of Research Investigations of the) Office of Research Integrity (USA) ORWH Office of Research on Woman’s Health (USA at NIH) OSHA Occupational Safety and Health Administration (USA) OTA Office of Technology Assessment OTC Over The Counter (Drugs) – frei verkäufliche Arzneimittel OTIS Teratology Information Services OVG Oberverwaltungsgericht
__________________
Wer versucht, mich zu ändern, ....muß mit Nebenwirkungen rechnen! |
|
|||
|
PA Product Authorization
PAGB Proprietary Association of Great Britain PAHO Pan-American Health Organisation PANDA Paper-assisted New Drug Application PASS Post Authorisation Safety Studies PBAC Pharmaceutical Benefits Advisory Committee (Australien) PBM Pharmaceutical Benefit Management PBM Pharmacy Benefit Management PBM Prescription Benefits Management PBS Pharmaceutical Benefit Scheme (Australien) PCA Predefined Change –Abnormal PCC Poison Control Center PD Pharmacodynamics PDE Permitted Daily Exposure PDF Portable Document Format (Adobe Systems Inc.) PDMA Prescription Drug Marketing Act PDP Product Development Protocol/Profile (Medical Devices – USA) PDQ Physicians‘ Data Query (NCI-sponsored cancer trial registry) PDR Physicians‘ Desk Reference (USA) PDUFA Prescription Drug User Fee Act (USA) PE Pharmacoeconomics PEC Predicted Effective Concentration PED Pediatric Exclusivity PEDI Pharmaceutical Electronic Data Interchange PEFRAS Pan European Federation of Regulatory Affairs Society PEI Paul-Ehrlich-Institut — Bundesamt für Sera und Impfstoffe siehe RKI PEM Prescription-Event Monitoring (UK) PEM Privacy Enhanced Mail PER Pharmaceutical Evaluation Reports Scheme (EMEA-CPMP) PER Pharmaceutical Evaluation Report Scheme PERI Pharmaceutical Education and Research Institute PHAGRO Bundesverband des pharmazeutischen Großhandels e.V. Pharm. Ind. Die Pharmazeutische Industrie (Pharma-Zeitschrift des ECV — Editio Cantor Verlag) PharmBetrV. Betriebsverordnung für pharmazeutische Unternehmer (Pharmabetriebsverordnung) PhRMA Pharmaceutical Research and Manufactures of America – amerikanischer Pharmaverband mit 67 Mitgliedern) PhVWP Pharmacovigilance Working Party (der CPMP bzw. EMEA) PIC Pharmaceutical Inspection Convention PKV Verband der privaten Krankenversicherungen e.V. PL Package Leaflet PM Produktmanagement PNEC Predicted No-Effect Concentration ProdHaftG Produkthaftungsgesetz PU (Pu) Pharmazeutischer Unternehmer PU (Pu) Pharmazeutischer Unternehmer
__________________
Wer versucht, mich zu ändern, ....muß mit Nebenwirkungen rechnen! |
|
|||
|
QA Quality Assurance
QC Quality Control QU-S (QS) Qualitätssicherungssystem QWP Quality Working Party
__________________
Wer versucht, mich zu ändern, ....muß mit Nebenwirkungen rechnen! |
|
|||
|
RAS Rapid Alert System der EU
(Risiko-Schnellwarnsystem der EU-Behörden) RIVM Rijksinstitute voor Volksgezondheid en Milieu, Netherlands RKI Robert-Koch-Institut — Bundesinstitut für Infektionskrankheiten und nicht übertragbare Krankheiten siehe auch PEI RL Richtlinie (directive) RMS Reference Member State - Referenzland bei dezentralem Zulassungsverfahren bei Erstzulassung
__________________
Wer versucht, mich zu ändern, ....muß mit Nebenwirkungen rechnen! |
|
|||
|
SE Surrogate Endpoint
SEA Single European Act of 1987 SEC Securities and Exchange Commission (USA) SEER Surveillance, Epidemiology, and End Results (Registry of NCI) SGB Sozialgesetzbuch SGB V Sozialgesetzbuch V SGML Standard Generalised Markup Language, ISO (International Organization for Standardization) 8879: construction of code structures for text coding, stored as ASCII (American Standard Code for Information Interchange) SGML (sgml) Standard Generalized Markup Language SIDC State Institute for Drug Control, Slovak Republic SIMG International Society of General Practice SMART Submission Management and Review Tracking SMDA Safe Medical Devices Act SME Significant Medical Event SMO Site Management Organisation SMRC Senior Management Review Committee (Canada) SND Standard Nomenclature Database (FDA) SNIP French Pharmaceutical Industry Association SNOMED Systematized Nomenclature of Medicine SOC System Organ Classes (MedDRA) SoCRA Society of Clinical Research Associates SOEP Socio-economic Panel SOP Standard Operation Procedures SOP Standard Operation Procedure — Standardarbeitsanweisung SPAC State Pharmaceutical Administration of China SPC Supplementary Patent SPC Supplementary Protection Certificate (for pharmaceutical patents) SPC (SmPC) Summary of Product Characteristics SQAP Systems Quality Assurance Plan SQL Standard/Structured Query Language - ISO 9075: methods for defining tables according to relational data base model, data storage and retrieval SR Spontaneous Report SRM Specific Risk Material SRS Spontaneous Reporting Schemes SSC Special Search Category (MedDRA) SSC Study Site Coordinator SSCT Swedish Society for Clinical Trials SSFA Società di Scienze Farmacologiche Applicate (Italy) STT Short Term Tests SUAW Schwerwiegende, unerwünschte Arzneimittelwirkung Serious Adverse Drug Reaction (Serious ADR) SUE Schwerwiegendes, unerwünschtes Ereignis Serious Adverse Event (SAE) SUKL State Institute for Drug Control, Czech Republic SWEDIS Swedish Drug Information System SWP Safety Working Party
__________________
Wer versucht, mich zu ändern, ....muß mit Nebenwirkungen rechnen! |
|
|||
|
TA Technology Assessment
TC Technical Committee (MPs) TC Telematic Committee (Directorate General III) TDDS Transdermal Delivery Device Systems TDDSG Teledienste-Datenschutzgesetz TDI Tolerable Daily Intake TDM Therapeutic Drug Monitoring TE Toxizitätsäquivalent TE True Endpoint TESS Treatment Emergent Signs and Symptoms TGA Therapeutic Goods Administration (Australia) TIFF Tagged Image File Format TIFF Tagged Image File Format TIND Treatment IND TIS Teratology Information Services TK Toxicokinetics TMF Trial Master File TMO Trial Management Organisation TQM Total Quality Management TRIPS Trade-related Aspects of Intellectual Property Rights TTK Tagestherapiekosten Technischer TÜV Technischer Überwachungsverein
__________________
Wer versucht, mich zu ändern, ....muß mit Nebenwirkungen rechnen! |
![]() |
| Lesezeichen |
| Themen-Optionen | |
| Ansicht | |
|
|